Skip to main content
. Author manuscript; available in PMC: 2014 Dec 23.
Published in final edited form as: ACS Nano. 2013 Dec 2;7(12):10834–10849. doi: 10.1021/nn404211j

Figure 8. Humoral immune responses after adoptive transfer of BMDCs.

Figure 8

OVA/AlOOH nanorod-primed BMDCs were i.p. injected into eight week old female C57BL/6 mice (6 animals per group) on day 0. On day 7, the animals were i.p. boosted with OVA/AlOOH nanorod-primed BMDCs. On day 14, the blood serum was collected to determine (A) IgG1 and (B) IgE titers. *p<0.05 compared to control mice; ap<0.05 compared to OVA-primed BMDC sensitized mice; #p<0.05 compared to OVA/Alum-primed BMDC sensitized mice.